AstraZeneca Wants 25 Opt-Ins Axed From Pay Bias Suit
More than two dozen women refused to take part in required discovery and should be removed from a collective action accusing AstraZeneca of paying female pharmaceutical sales representatives less than men, the company told...To view the full article, register now.
Already a subscriber? Click here to view full article